Vivos Therapeutics Inc
NASDAQ:VVOS

Watchlist Manager
Vivos Therapeutics Inc Logo
Vivos Therapeutics Inc
NASDAQ:VVOS
Watchlist
Price: 2.06 USD 1.48% Market Closed
Market Cap: 18.5m USD

Wall Street
Price Targets

VVOS Price Targets Summary
Vivos Therapeutics Inc

Wall Street analysts forecast VVOS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for VVOS is 5.61 USD with a low forecast of 4.04 USD and a high forecast of 7.35 USD.

Lowest
Price Target
4.04 USD
96% Upside
Average
Price Target
5.61 USD
172% Upside
Highest
Price Target
7.35 USD
257% Upside
Vivos Therapeutics Inc Competitors:
Price Targets
9860
Adicon Holdings Ltd
100% Upside
VOX
Voxel SA
49% Upside
ATRY
Atrys Health SA
107% Upside
EUDA
EUDA Health Holdings Ltd
162% Upside
PINC
Premier Inc
45% Upside
600763
Topchoice Medical Co Inc
18% Upside
1951
Jinxin Fertility Group Ltd
50% Upside
DNTL
dentalcorp Holdings Ltd
5% Upside

Revenue
Forecast

Revenue Estimate
Vivos Therapeutics Inc

For the last 5 years the compound annual growth rate for Vivos Therapeutics Inc's revenue is 6%. The projected CAGR for the next 2 years is 35%.

6%
Past Growth
35%
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Vivos Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
3%
Average Beat

Net Income
Forecast

Net Income Estimate
Vivos Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-90%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is VVOS's stock price target?
Price Target
5.61 USD

According to Wall Street analysts, the average 1-year price target for VVOS is 5.61 USD with a low forecast of 4.04 USD and a high forecast of 7.35 USD.

What is Vivos Therapeutics Inc's Revenue forecast?
Projected CAGR
35%

For the last 5 years the compound annual growth rate for Vivos Therapeutics Inc's revenue is 6%. The projected CAGR for the next 2 years is 35%.

Back to Top